There is a new requirement for medical device companies selling into the European market, called the Medical Device Regulation, or MDR. This new regulation places a focus on the supply chain, meaning suppliers in the industry must have a good understanding of the new...
In an Australasian BioTechnology article, Facilities for a Strong Future, Emerson’s Michalle Adkins and Makarand Mujumdar share how pharmaceutical and biotech manufacturers can improve local capacity to meet the needs of the regions in which they operate.
There are four core pillars we look to address in order to support pharmaceutical and biopharmaceutical manufacturers in achieving line and facility efficiency goals.
Reliability of assets used in the manufacturing process is paramount for safe, efficient and effective operations. Unplanned asset failures, improper asset performance, poor maintenance planning, and untimely follow-through can cause shutdowns, under-utilized production equipment, deviations, or material/product losses.
Initiating Good Manufacturing Practices (GMP) production operations, whether as part of facility start-up, product changeover, or following a shutdown, requires complex coordination of both logical and physical process controls. Inefficient configuration and qualification practices for automation and information management systems can lead to both start-up delays and productivity losses.
In Ben Arriola’s article, Introducing the Next-Generation Single-Use pH Sensor, he describes how advancements in single-use sensors have improved quality, reliability, and the level of supplier support.
There is little doubt that the recent explosion in available cloud technologies has been a boon for manufacturing across a wide array of industries. Pharmaceutical manufacturers are no exception, and organizations are now carefully considering where leveraging cloud...
Neo Chow Yang shares how Emerson’s Real-Time Modeling System allows users to visualize the facility constraints, accommodate variability, maximize production, and understand the implications of any change in the manufacturing process.
As consumers of medicinal products of various kinds (vaccines, immunotherapies, tablets, capsules, cell therapies, etc.), we know that although product quality is important, reliable supply is also critical. A reliable supplier of therapeutic goods requires the...
Success must be supported so it can be sustained. As Chris Jensen and H.P. Slater discuss in an article in the July issue of Process Heating, this line of thinking is no less true in predictive maintenance (PdM) than in anything else. Some companies are impressed with...
For manufacturers in the Life Sciences industry, production challenges often occur in these four areas—production readiness, equipment reliability, personnel effectiveness and facility/line efficiency. In this post, I’ll focus on equipment reliability, and specifically, unplanned downtime.
Flow is the foundation of world class production processes. Impediments to flow result in waste (transportation, inventory, motion, waiting, over-processing, over-production, defects). Unfortunately, digital solutions are often leveraged to address observed wastes in production processes without first addressing foundational problems.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.